Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Embolism and VKORC1[original query] |
|---|
| VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study. Clinical orthopaedics and related research 2009 Jul 467 (7): 1773-80. González Della Valle Alejandro, Khakharia Saurabh, Glueck Charles J, Taveras Nicole, Wang Ping, Fontaine Robert N, Salvati Eduardo |
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
PLoS genetics 2009 Mar 5 (3): e1000433. Takeuchi Fumihiko, McGinnis Ralph, Bourgeois Stephane, Barnes Chris, Eriksson Niclas, Soranzo Nicole, Whittaker Pamela, Ranganath Venkatesh, Kumanduri Vasudev, McLaren William, Holm Lennart, Lindh Jonatan, Rane Anders, Wadelius Mia, Deloukas Pan |
| A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists. Journal of applied genetics 2009 50 (4): 399-403. Stepien E, Branicka A, Ciesla-Dul M, Undas |
| Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients. Pharmacogenetics and genomics 2011 Mar 21 (3): 130-5. Shahin Mohamed Hossam A, Khalifa Sherief I, Gong Yan, Hammad Lamiaa N, Sallam Mohamed T H, El Shafey Mostafa, Ali Shawky S, Mohamed Mohamed-Eslam F, Langaee Taimour, Johnson Julie |
| Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
| Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model. Thrombosis journal 2013 11 (1): 14. Nshimyumukiza Léon, Duplantie Julie, Gagnon Mathieu, Douville Xavier, Fournier Diane, Lindsay Carmen, Parent Marc, Milot Alain, Giguère Yves, Gagné Christian, Rousseau François, Reinharz Dani |
| [A randomized controlled study of the VKORC1 and CYP2C9 genotypes in guiding warfarin therapy for pulmonary thromboembolism]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2013 Dec 36 (12): 950-3. Li Jie, Liu Shuang, Yang Jing-hua, Guo Wei, Wang Zeng-zhi, Chen Yong, Wang Sheng-h |
| [Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population]. Zhonghua yi xue za zhi 2016 Mar 96 (10): 776-80. Li C B, Dai D P, Hu G X, Pu C W, Cao Y P, Cai J |
| High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
| The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 Apr 34 (2): 328-336. Bedewy Ahmed M L, Sheweita Salah A, Mostafa Mostafa Hasan, Kandil Lamia Sae |
| Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study. Clinical cardiology 2018 3 41 (5): 576-585. Perreault Sylvie, Shahabi Payman, Côté Robert, Dumas Stéphanie, Rouleau-Mailloux Étienne, Feroz Zada Yassamin, Provost Sylvie, Mongrain Ian, Dorais Marc, Huynh Thao, Kouz Simon, Diaz Ariel, Blostein Mark, de Denus Simon, Turgeon Jacques, Ginsberg Jeffrey, Lelorier Jacques, Lalonde Lyne, Busque Lambert, Kassis Jeannine, Talajic Mario, Tardif Jean-Claude, Dubé Marie-Pier |
| Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020 4 26 1076029620909154. Rojo Mario, Roco Angela Margarita, Suarez Marcelo, Lavanderos Maria Alejandra, Verón Gabriel, Bertoglia Maria Paz, Arredondo Annabella, Nieto Elena, Rubilar Juan Carlos, Tamayo Francisca, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Véliz Paulo, Godoy Gerald, Varela Nelson Miguel, Llull G, Quiñones Luis Ab |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: